Quest Diagnostics Inc Business Acquisition, Pro Forma Revenue
Quest Diagnostics Inc (DGX) reported Business Acquisition, Pro Forma Revenue of $10.32 billion for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Income Statement › Other Income
us-gaap:BusinessAcquisitionsProFormaRevenue · last filed 2026-02-26
- Quest Diagnostics Inc business acquisition, pro forma revenue for the quarter ending 2024-12-31 was $2.62B, a 7.11% increase year-over-year.
- Quest Diagnostics Inc business acquisition, pro forma revenue for the quarter ending 2024-09-30 was $2.59B, a 5.16% increase year-over-year.
- Quest Diagnostics Inc business acquisition, pro forma revenue for the quarter ending 2024-06-30 was $2.58B.
- Quest Diagnostics Inc business acquisition, pro forma revenue for the quarter ending 2024-03-31 was $2.54B.
- Quest Diagnostics Inc business acquisition, pro forma revenue for fiscal 2024 was $10.32B, a 4.06% increase from fiscal 2023.
- Quest Diagnostics Inc business acquisition, pro forma revenue for fiscal 2023 was $9.92B.
- Quest Diagnostics Inc business acquisition, pro forma revenue for fiscal 2014 was $7.52B, a 1.34% decline from fiscal 2013.
- Quest Diagnostics Inc business acquisition, pro forma revenue for fiscal 2013 was $7.62B.
| Period end | Business Acquisition, Pro Forma Revenue 3 month | Business Acquisition, Pro Forma Revenue 6 month | Business Acquisition, Pro Forma Revenue 9 month | Business Acquisition, Pro Forma Revenue 12 month |
|---|---|---|---|---|
| 2024-12-31 | $2.62B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.21B derived: sum of 2 quarters · filed 2026-02-26 | $7.79B derived: sum of 3 quarters · filed 2026-02-26 | $10.32B 10-K · filed 2026-02-26 |
| 2024-09-30 | $2.59B 10-Q · filed 2025-10-21 | $5.17B derived: sum of 2 quarters · filed 2025-10-21 | $7.70B 10-Q · filed 2025-10-21 | $10.15B derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $2.58B 10-Q · filed 2025-07-23 | $5.11B 10-Q · filed 2025-07-23 | $7.56B derived: sum of 3 quarters · filed 2026-02-26 | $10.02B derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $2.54B 10-Q · filed 2025-04-23 | $4.98B derived: sum of 2 quarters · filed 2026-02-26 | $7.44B derived: sum of 3 quarters · filed 2026-02-26 | |
| 2023-12-31 | $2.45B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.91B derived: sum of 2 quarters · filed 2026-02-26 | $9.92B 10-K · filed 2026-02-26 | |
| 2023-09-30 | $2.46B 10-Q · filed 2024-10-23 | $7.47B 10-Q · filed 2024-10-23 | ||
| 2014-12-31 | $1.88B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | $3.79B derived: sum of 2 quarters · filed 2017-02-22 | $5.69B derived: sum of 3 quarters · filed 2017-02-22 | $7.52B 10-K · filed 2017-02-22 |
| 2014-09-30 | $1.90B derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $3.81B derived: sum of 2 quarters · filed 2014-10-30 | $5.64B 10-Q · filed 2014-10-30 | $7.52B derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | $1.91B 10-Q · filed 2014-07-31 | $3.73B 10-Q · filed 2014-07-31 | $5.62B derived: sum of 3 quarters · filed 2016-02-26 | $7.53B derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | $1.83B 10-Q · filed 2015-04-30 | $3.71B derived: sum of 2 quarters · filed 2016-02-26 | $5.62B derived: sum of 3 quarters · filed 2016-02-26 | $7.55B derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | $1.88B derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $3.79B derived: sum of 2 quarters · filed 2016-02-26 | $5.72B derived: sum of 3 quarters · filed 2016-02-26 | $7.62B 10-K · filed 2016-02-26 |
| 2013-09-30 | $1.91B 10-Q · filed 2014-10-30 | $3.84B derived: sum of 2 quarters · filed 2014-10-30 | $5.74B 10-Q · filed 2014-10-30 | |
| 2013-06-30 | $1.93B 10-Q · filed 2014-07-31 | $3.83B 10-Q · filed 2014-07-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |